Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
暂无分享,去创建一个
J. Kładny | A. Jakubowska | J. Lubiński | C. Cybulski | W. Kluźniak | T. Byrski | T. Huzarski | M. Lener | P. Baszuk | S. Pietrzak | Rodney J. Scott | A. Wiechowska‐Kozłowska | A. Soluch
[1] E. Smith. PALB2 and the risks for cancer: implications for clinical care. , 2015, Oncology nursing forum.
[2] Raymond M. Moore,et al. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[3] A. Jakubowska,et al. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. , 2015, The Lancet. Oncology.
[4] D. Hedley,et al. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Kench,et al. Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.
[6] H. Frucht,et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. , 2014, World journal of gastroenterology.
[7] Alison P. Klein,et al. An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population , 2013, PloS one.
[8] A. Jakubowska,et al. The risk of gastric cancer in carriers of CHEK2 mutations , 2013, Familial Cancer.
[9] K. Strauch,et al. PALB2 mutations in European familial pancreatic cancer families , 2010, Clinical genetics.
[10] P. Souček,et al. CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer. , 2010, Cancer epidemiology.
[11] Wei Zheng,et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.
[12] Geoffrey S. Tobias,et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.
[13] V. Kalinin,et al. K-ras, BRCA1/2, and CHEK2 mutations and loss of heterozygosity at 9p, 17p, and 18q in sporadic adenocarcinoma of the pancreas , 2009, Molecular Biology.
[14] V. Kalinin,et al. [Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas]. , 2009, Молекулярная биология.
[15] Alison P. Klein,et al. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.
[16] J. Lubiński,et al. Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer , 2008, International journal of cancer.
[17] A. Jakubowska,et al. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland , 2007, Breast Cancer Research and Treatment.
[18] A. Borkowski,et al. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer , 2006, Journal of Medical Genetics.
[19] S. Hahn,et al. Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer , 2006, Familial Cancer.
[20] K. Chrzanowska,et al. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of polish pediatric patients with sporadic lymphoid malignancies , 2006, International journal of cancer.
[21] A. Jakubowska,et al. Breast cancer predisposing alleles in Poland , 2005, Breast Cancer Research and Treatment.
[22] J. Lubiński,et al. CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.
[23] Karl Sperling,et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in poland , 2004, International journal of cancer.
[24] Alison P. Klein,et al. Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.
[25] A. Jakubowska,et al. Hereditary ovarian cancer in Poland. , 2004, International journal of cancer.
[26] A. Jakubowska,et al. NBS1 Is a Prostate Cancer Susceptibility Gene , 2004, Cancer Research.
[27] Maria Chosia,et al. Germline 657del5 mutation in the NBS1 gene in breast cancer patients , 2003, International journal of cancer.
[28] E. Seemanová,et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations , 2000, European Journal of Human Genetics.
[29] Matthias Platzer,et al. Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome , 1998, Cell.
[30] C. Moskaluk,et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.
[31] K. Lillemoe,et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. , 1994, Journal of the National Cancer Institute.